Kenneth E. Hook
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 3
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Wilbur R. Leopold (5 shared papers)David W. Fry (4 shared papers)James M. Nelson (1 shared paper)James L. Hicks (1 shared paper)Joseph A. Loo (1 shared paper)Ellen M. Dobrusin (1 shared paper)Annette M. Doherty (1 shared paper)Alexander J. Bridges (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (4 papers)Investigational New Drugs (2 papers)Proceedings of the National Academy of Sciences (1 paper)Osteoarthritis and Cartilage (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesNew Zealand
In The Last Decade
Kenneth E. Hook
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Oncology 273
- Pulmonary and Respiratory Medicine 201
- Rheumatology 87
- Cell Biology 82
- Organic Chemistry 163
Countries citing papers authored by Kenneth E. Hook
This map shows the geographic impact of Kenneth E. Hook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth E. Hook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth E. Hook more than expected).
Fields of papers citing papers by Kenneth E. Hook
This network shows the impact of papers produced by Kenneth E. Hook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth E. Hook. The network helps show where Kenneth E. Hook may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth E. Hook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 373 | |
| 2 | 2008 | 200 | |
| 3 | 2006 | 126 | |
| 4 | 2012 | 88 | |
| 5 | Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. | 2000 | 85 |
| 6 | 2010 | 80 | |
| 7 | 1995 | 56 | |
| 8 | 1985 | 40 | |
| 9 | 2013 | 32 | |
| 10 | 1995 | 13 | |
| 11 | In vivo and in vitro evaluation of the alkylating agent carmethizole. | 1991 | 10 |
| 12 | 2003 | 5 | |
| 13 | 1996 | 4 | |
| 14 | 1989 | 3 |
About Kenneth E. Hook
Kenneth E. Hook is a scholar working on Oncology, Toxicology, Cell Biology, Molecular Biology and Pharmacology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Microtubule and mitosis dynamics (2 papers), Biochemical and Molecular Research (2 papers), Growth Hormone and Insulin-like Growth Factors (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Cancer therapeutics and mechanisms (1 paper) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Oncology (273 citations), Pulmonary and Respiratory Medicine (201 citations), Rheumatology (87 citations), Cell Biology (82 citations) and Organic Chemistry (163 citations). Kenneth E. Hook has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Wilbur R. Leopold, David W. Fry, James M. Nelson, James L. Hicks, Joseph A. Loo, Ellen M. Dobrusin, Annette M. Doherty, Alexander J. Bridges, Dennis J. McNamara and Jeff Bruce Smaill. Their work appears in journals such as Molecular Cancer Therapeutics, Investigational New Drugs, Proceedings of the National Academy of Sciences, Osteoarthritis and Cartilage and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.